Biblio
Found 76 results
[ Author] Keyword Title Type Year Filters: First Letter Of Keyword is R [Clear All Filters]
“Genetic association between endothelial nitric oxide synthase and Alzheimer disease.”, Clin Genet, vol. 70, no. 1, pp. 49-56, 2006.
, “Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.”, PLoS One, vol. 10, no. 10, p. e0141836, 2015.
, “Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.”, PLoS One, vol. 10, no. 10, p. e0141836, 2015.
, “Genetic variants in a 'cAMP element binding protein' (CREB)-dependent histone acetylation pathway influence memory performance in cognitively healthy elderly individuals.”, Neurobiol Aging, vol. 35, no. 12, pp. 2881.e7-2881.e10, 2014.
, “Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 1, pp. 35-43, 2009.
, “Overview and findings from the religious orders study.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 628-45, 2012.
, “Overview and findings from the religious orders study.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 628-45, 2012.
, “Overview and findings from the rush Memory and Aging Project.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 646-63, 2012.
, “A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.”, JAMA Neurol, vol. 72, no. 4, pp. 414-22, 2015.
, “Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”, Hum Mol Genet, vol. 19, no. 16, pp. 3295-301, 2010.
, “Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.”, Alzheimers Dement, vol. 13, no. 12, pp. 1410-1413, 2017.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.”, Alzheimers Dement, vol. 12, no. 2, pp. 121-129, 2016.
, “Genetic association of low density lipoprotein receptor and Alzheimer's disease.”, Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, , “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “High-throughput identification of long-range regulatory elements and their target promoters in the human genome.”, Nucleic Acids Res, vol. 41, no. 9, pp. 4835-46, 2013.
, “Transethnic genome-wide scan identifies novel Alzheimer's disease loci.”, Alzheimers Dement, vol. 13, no. 7, pp. 727-738, 2017.
,